Targeted Genomics Launches CeliacDx Consumer-Initiated Testing Service
IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Targeted Genomics LLC, developer of GlutenID, the only U.S. Food and Drug...
Healthcare
AssistRx Named a Winner of the Orlando Sentinel Media Group’s Central Florida Top Workplaces 2025 Award
Healthcare technology and patient solutions provider recognized as a Central Florida top employer for fifth consecutive yearORLANDO, Fla., Oct. 28,...
R1 Welcomes Estelle Barnes to Lead Enterprise Customer Engagement and Partnerships
MURRAY, Utah, Oct. 28, 2025 (GLOBE NEWSWIRE) -- R1 (“R1” or the “Company”), the leader in healthcare revenue management, today...
Kestra Medical Technologies to Present at the Stifel 2025 Healthcare Conference
KIRKLAND, Wash., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital...
Madrigal to Present New Data from the Company’s MASH Program at AASLD’s The Liver Meeting 2025
Two oral presentations to highlight biomarker, imaging and quality-of-life data from the open-label compensated MASH cirrhosis (F4c) arm of the...
ProPhase Labs Engages RedChip Companies to Lead Investor Relations Efforts
UNIONDALE, NY, Oct. 28, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (the “Company” or “ProPhase”), a next generation...
Kiniksa Pharmaceuticals Reports Third Quarter 2025 Financial Results and Recent Portfolio Execution
– ARCALYST® (rilonacept) Q3 2025 net product revenue of $180.9 million, representing 61% year-over-year growth –– ARCALYST 2025 expected net...
Context Therapeutics to Participate in Upcoming Investor Conferences
PHILADELPHIA, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company...
TG Therapeutics Completes Enrollment in the Phase 3 ENHANCE Trial Evaluating its New Simplified Dosing Schedule for BRIUMVI
NEW YORK, Oct. 28, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), announced today that enrollment has completed in...
Causeway Therapeutics Debuts Positive Data from Phase 2 Clinical Trial of TenoMiR® for Lateral Epicondylitis
Data Show Statistically Significant Improvements in Pain, Function and Tendon Structure in Appropriately Dosed PatientsGLASGOW, Scotland, Oct. 28, 2025 (GLOBE...
SEAL Analytical Launches New Website Featuring Bioz Badges, Applauds Seamless Integration and Service Excellence
PALO ALTO, CA / ACCESS Newswire / October 28, 2025 / Bioz, Inc., a driving force behind AI citation insight...
Zenni Optical Brings Together Leading Voices in Technology and Wellness to Celebrate the Launch of EyeQLenz™ with Zenni ID Guard™
SAN FRANCISCO, Oct. 27, 2025 /PRNewswire/ -- Following the debut of EyeQLenz™ with Zenni ID Guard™, Bay Area-based Zenni Optical...
FSA Store® Shares 4 Steps to Avoid Forfeiting Flexible Spending Account (FSA) Funds to the December 31 Use-It-Or-Lose-It Deadline
Consumers forfeit an estimated $3 billion each year because they fail to spend their FSA contributions by December 31; FSA...
Honey Health Raises $7.8M to Automate Healthcare’s Back Office With Autonomous AI Agents
The all-in-one AI back office platform is already working with 100+ organizations, saving them millions in administrative overhead MOUNTAIN VIEW,...
IR-MED’s Key Clinical and Media Milestones
PressureSafe(TM) clinical results presented to global nursing leaders; the Company engages with U.S. investment community and national media in parallel...
ForHumanity™ Launches VigorAir™: The Only Doctor-Prescribed ED Treatment Powered by Breath
Innovative telehealth startup introduces inhalable ED and migraine relief plus a gut-friendly metformin gummy for blood sugar and longevity SAN...
Sales Training Software Market to Reach $12.2 Billion by 2034 Globally, at 13.5% CAGR: Allied Market Research
The global sales training software market is experiencing rapid growth due to increase in demand for voice-enabled applications, advancements in natural...
Avanos Medical, Inc. to Webcast Conference Call Discussing Third Quarter 2025 Financial Results
ALPHARETTA, Ga., Oct. 27, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results...
Electronic Trial Master File (eTMF) Systems Market worth $2.49 billion by 2030 with 12.8% CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., Oct. 27, 2025 /PRNewswire/ -- The global Electronic Trial Master File (eTMF) Systems Market, valued at US$1.21 billion...
Chromatin Bioscience Announces Collaboration with Purespring Therapeutics
EDINBURGH, Scotland, Oct. 27, 2025 /PRNewswire/ -- Chromatin Bioscience is pleased to announce an ongoing research collaboration with Purespring Therapeutics, a...